Vancomycin Hydrochloride 250mg Infusion

Vancomycin Hydrochloride 250mg is a glycopeptide antibiotic injection used in hospital or supervised-care settings for serious infections caused by susceptible gram-positive bacteria, including resistant organisms such as MRSA when prescribed. It may be used for bloodstream infection, endocarditis, pneumonia, bone and joint infection, skin and soft-tissue infection, and perioperative prophylaxis in selected high-risk patients.
The infusion team prepares and dilutes the medicine before giving it slowly into a vein. Infusion lasts at least 60 minutes and may take longer according to the dose and reaction risk; it is never given as a rapid IV push. Kidney function and exposure measurements guide subsequent doses.
Vancomycin inhibits bacterial cell-wall synthesis in susceptible gram-positive bacteria, stopping bacterial growth and survival.
Possible effects include infusion-site irritation, flushing, itching, rash, nausea, fever, and infusion reaction. Serious concerns include kidney injury, hearing problems, low white blood cells, severe skin reactions, and C. difficile diarrhoea.
Tell the infusion team about kidney or hearing problems or a previous vancomycin reaction. Mention pregnancy, breastfeeding, aminoglycosides, amphotericin, NSAIDs, contrast dye and other medicines that can injure the kidneys. Culture results, kidney function and vancomycin levels guide treatment; the infusion rate affects reactions.
Treats susceptible serious gram-positive infections, including MRSA, when adequate concentrations reach the infection site.
Vancomycin Hydrochloride 250mg is used for serious susceptible gram-positive infections in supervised care.
Rapid infusion can cause flushing, itching, low blood pressure, breathing symptoms, and infusion reactions.
Kidney function, hearing symptoms, blood counts, infection response, and vancomycin levels may be monitored.
Intravenous vancomycin does not reliably deliver the bowel-lumen exposure needed for this infection. Oral vancomycin has a different treatment role and is not substituted by simply infusing the same amount.
Severe rash, hearing changes, low urine, severe diarrhoea, breathing trouble, or infusion reaction needs urgent attention.
Glycopeptide: an antibiotic class that inhibits bacterial cell-wall synthesis. MRSA: methicillin-resistant Staphylococcus aureus. Infusion reaction: flushing, itching or low blood pressure related to infusion exposure and speed. AUC monitoring: assessment of total medicine exposure over time. Nephrotoxicity: kidney injury caused by a substance.; AR: Vancomycin Hydrochloride 250mg تسريب وريدي; FR: Vancomycin Hydrochloride 250mg perfusion intraveineuse; PT: Vancomycin Hydrochloride 250mg infusão intravenosa; ES: Vancomycin Hydrochloride 250mg perfusión intravenosa; RU: Vancomycin Hydrochloride 250mg внутривенная инфузия; ID: Vancomycin Hydrochloride 250mg infus intravena; VI: Vancomycin Hydrochloride 250mg dung dịch truyền tĩnh mạch; MS: Vancomycin Hydrochloride 250mg infusi intravena; TL: Vancomycin Hydrochloride 250mg pagbubuhos sa ugat; ZH-SG: Vancomycin Hydrochloride 250mg 静脉输注剂
International B2B Enquiry
Send a structured B2B enquiry for Vancomycin Hydrochloride 250mg Infusion under Antibiotics. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Vancomycin Hydrochloride 250mg Infusion